Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an

Manufacturer Up In Arms Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, angeri

Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an

The moratorium on human embryo research coincided with the Republican presidencies of Ronald Reagan and George Bush. Both administrations opposed abortion, with support from some conservative political and religious groups, based on the view that human life begins when the ovum is fertilized and that the resulting embryo has legal rights to protection similar to those of an infant, child, or adult. In recent years, the Bush administ

Back to:New Funds Possible for Embryo Research The ethical reasoning of the panel advising the National Institutes of Health on human embryo research was clearly expressed by its policy cochairwoman at a news conference at which the group's report was released in September. "The basic finding of the panel is that it is acceptable public policy to fund research on the human embryo, subject to stringent guidelines," said Pa

Back to:New Funds Possible for Embryo Research The ethical reasoning of the panel advising the National Institutes of Health on human embryo research was clearly expressed by its policy cochairwoman at a news conference at which the group's report was released in September. "The basic finding of the panel is that it is acceptable public policy to fund research on the human embryo, subject to stringent guidelines," said Pa

The moratorium on human embryo research coincided with the Republican presidencies of Ronald Reagan and George Bush. Both administrations opposed abortion, with support from some conservative political and religious groups, based on the view that human life begins when the ovum is fertilized and that the resulting embryo has legal rights to protection similar to those of an infant, child, or adult. In recent years, the Bush administ

Interview With: FRANKLIN HOKE, pp.12 Date: November 14, 1994 Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in P

"Gallo's meeting has juice, that's what it's got," declares Cecil H. Fox, an experimental pathologist, biochemist, and 20-year NIH veteran who is now president of Molecular Histology Laboratories Inc., Gaithersburg, Md. "That is, there's a lot of interpersonal contact, there are colorful people that go to it, there are discussions, disagreements, and, frequently, hard feelings and good feelings that come out of it. It's what scienti

Interview With: FRANKLIN HOKE, pp.12 Date: November 14, 1994 Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in P

"Gallo's meeting has juice, that's what it's got," declares Cecil H. Fox, an experimental pathologist, biochemist, and 20-year NIH veteran who is now president of Molecular Histology Laboratories Inc., Gaithersburg, Md. "That is, there's a lot of interpersonal contact, there are colorful people that go to it, there are discussions, disagreements, and, frequently, hard feelings and good feelings that come out of it. It's what scienti

In 1993, the Food and Drug Administration (FDA) declined to approve Malvern, Pa.-based Centocor Inc.'s lead compound, Centoxin, sending the company into a near-fatal financial tailspin. Today, after a drastic retrenching, Centocor has recovered to be listed as one of the top 10 biotechnology firms by market valuation in the Ernst and Young report "Biotech '95: Reform, Restruc- ture, Renewal." A new angioplasty therapeutic called R